Zymenex A/S

Zymenex develops pharmaceutical products to treat rare, serious and genetic diseases. The company’s goal is to develop a successive number of enzyme replacement therapies for diseases, which may have an orphan drug potential. 

Contact name:

Jens Fogh


Roskildevej 12 C, 3400 Hillerød, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2010 Danskbiotek. All rights reserved.